argenex (ARGX) News Today $560.24 -3.07 (-0.54%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$560.62 +0.38 (+0.07%) As of 07/11/2025 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ARGX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGXJuly 12 at 10:00 AM | prnewswire.comargenex SE (NASDAQ:ARGX) Given Average Rating of "Buy" by BrokeragesJuly 11 at 2:43 AM | marketbeat.comARGX - argenx SE ADR Financials - MorningstarJuly 9, 2025 | morningstar.comMHarvey Capital Management Inc. Decreases Holdings in argenex SE (NASDAQ:ARGX)July 9, 2025 | marketbeat.comargenex (NASDAQ:ARGX) Upgraded to Buy at Deutsche Bank AktiengesellschaftJuly 9, 2025 | americanbankingnews.comCambridge Investment Research Advisors Inc. Purchases Shares of 985 argenex SE (NASDAQ:ARGX)July 9, 2025 | marketbeat.comEuropean shares flat as investors assess new US tariff proposalsJuly 8, 2025 | msn.comargenex (NASDAQ:ARGX) Raised to "Buy" at Deutsche Bank AktiengesellschaftJuly 8, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGXJuly 7, 2025 | prnewswire.com2,640 Shares in argenex SE (NASDAQ:ARGX) Acquired by Calamos Advisors LLCJuly 7, 2025 | marketbeat.comARGX - argenx SE ADR Key Metrics - MorningstarJuly 5, 2025 | morningstar.comMargenex (NASDAQ:ARGX) Earns Overweight Rating from Analysts at Morgan StanleyJuly 4, 2025 | americanbankingnews.comargenex (NASDAQ:ARGX) Now Covered by Morgan StanleyJuly 3, 2025 | marketbeat.comargenex's (ARGX) Buy Rating Reaffirmed at HC WainwrightJuly 3, 2025 | americanbankingnews.com7ARGX : Here's How Much You Would Have Made Owning argenx...July 2, 2025 | benzinga.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGXJuly 2, 2025 | prnewswire.comHC Wainwright Reiterates "Buy" Rating for argenex (NASDAQ:ARGX)July 1, 2025 | marketbeat.comargenx NV ADR News (ARGX) - Investing.comJuly 1, 2025 | investing.comArgenx's CIDP Challenge: A Safety Signal Points To Operational Refinement, Not RuinJune 30, 2025 | seekingalpha.comArgenx stock falls after FDA flags serious risk signal with VyvgartJune 30, 2025 | za.investing.comargenx down 7% as FDA identifies possible safety signal with Vyvgart HytruloJune 30, 2025 | msn.comBofA Remains Bullish on Argenx (ARGX) With a Buy Rating and $804 PTJune 30, 2025 | msn.comargenex (NASDAQ:ARGX) Stock Price Down 7.7% - Time to Sell?June 30, 2025 | marketbeat.comFDA Flags Major Safety Concerns For Argenx's Nerve Disorder Drug, Stock FallsJune 30, 2025 | benzinga.comargenx SE: argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic SyndromesJune 30, 2025 | finanznachrichten.deTranscend Capital Advisors LLC Invests $342,000 in argenex SE (NASDAQ:ARGX)June 30, 2025 | marketbeat.comargenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic SyndromesJune 30, 2025 | tmcnet.comAllspring Global Investments Holdings LLC Grows Stock Holdings in argenex SE (NASDAQ:ARGX)June 29, 2025 | marketbeat.comEvercore ISI Keeps Their Buy Rating on Argenx Se (ARGX)June 27, 2025 | theglobeandmail.comPerpetual Ltd Decreases Stock Holdings in argenex SE (NASDAQ:ARGX)June 27, 2025 | marketbeat.comEnvestnet Portfolio Solutions Inc. Cuts Position in argenex SE (NASDAQ:ARGX)June 27, 2025 | marketbeat.comArgenx Secures EC Approval for Subcutaneous VYVGART in CIDP TreatmentJune 24, 2025 | msn.comargenex (NASDAQ:ARGX) Given Outperform Rating at WedbushJune 24, 2025 | marketbeat.comSowell Financial Services LLC Takes $332,000 Position in argenex SE (NASDAQ:ARGX)June 22, 2025 | marketbeat.comRhumbline Advisers Sells 2,213 Shares of argenex SE (NASDAQ:ARGX)June 21, 2025 | marketbeat.comArgenx Gets European Commission Approval For Drug To Treat Rare Autoimmune Disease, But Stock Fails To Garner Retail AttentionJune 20, 2025 | msn.comargenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating PolyneuropathyJune 20, 2025 | globenewswire.comWedbush Comments on argenex's Q2 Earnings (NASDAQ:ARGX)June 18, 2025 | marketbeat.comEquities Analysts Issue Forecasts for argenx Q4 EarningsJune 17, 2025 | marketbeat.comargenx (NASDAQ:ARGX) Shares Down 3.3% - Should You Sell?June 16, 2025 | marketbeat.comargenx SE (NASDAQ:ARGX) Given Consensus Rating of "Buy" by BrokeragesJune 16, 2025 | marketbeat.comargenx SE (NASDAQ:ARGX) Shares Purchased by Assenagon Asset Management S.A.June 12, 2025 | marketbeat.comWedbush Reiterates "Outperform" Rating for argenx (NASDAQ:ARGX)June 11, 2025 | marketbeat.comargenx SE (NASDAQ:ARGX) Shares Bought by Handelsbanken Fonder ABJune 11, 2025 | marketbeat.comargenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s DiseaseJune 10, 2025 | finance.yahoo.comargenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's DiseaseJune 10, 2025 | globenewswire.comHC Wainwright Reaffirms Buy Rating for argenx (NASDAQ:ARGX)June 10, 2025 | marketbeat.comargenx SE (ARGX): A Bull Case TheoryJune 6, 2025 | insidermonkey.comBarclays Boosts Argenx (ARGX) PT to EUR 680 After Strong Q1 2025 PerformanceJune 6, 2025 | msn.comargenx to Present at Goldman Sachs 46th Annual Global Healthcare ConferenceJune 3, 2025 | globenewswire.com Get argenex News Delivered to You Automatically Sign up to receive the latest news and ratings for ARGX and its competitors with MarketBeat's FREE daily newsletter. Email Address ARGX Media Mentions By Week ARGX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARGX News Sentiment▼0.880.99▲Average Medical News Sentiment ARGX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARGX Articles This Week▼1311▲ARGX Articles Average Week Get argenex News Delivered to You Automatically Sign up to receive the latest news and ratings for ARGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNY News GSK News TAK News BNTX News ONC News TEVA News INSM News SMMT News ITCI News GMAB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARGX) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding argenex SE Please log in to your account or sign up in order to add this asset to your watchlist. Share argenex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
